Evidence map›Paper›PMID 40462783›Full record

ArticleCureus2025

A Case of Ertapenem-Induced Neurotoxicity in an Elderly Patient With Reduced Renal Function.

Wyut Yi Htay, Wai Lin Aung, Wah Pwint Phyu

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wyut Yi HtayGeriatrics, West Middlesex University Hospital, London, GBR.
Wai Lin AungGeneral Medicine, West Middlesex University Hospital, London, GBR.
Wah Pwint PhyuGeriatrics, West Middlesex University Hospital, London, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ertapenem-induced neurotoxicity is a rare, often underreported side effect, primarily seen in elderly patients with impaired renal function. We report the case of an 87-year-old woman with a history of chronic kidney disease (CKD) and bilateral hydronephrosis, who presented with acute neurological symptoms, including left-sided weakness and slurred speech. Prior to this presentation, she had been treated for a left-sided nephrostomy site infection and left-sided perinephric collection with intravenous ertapenem at an ambulatory emergency care (AEC) center. An initial computed tomography (CT) scan of the brain showed no acute changes, but we treated her for a possible stroke while awaiting a magnetic resonance imaging (MRI) scan of the brain and continued intravenous ertapenem for the associated urological infection. However, the patient's condition continued to deteriorate, with the onset of further neurological symptoms, such as left-sided sensory deficits and constant myoclonic movements. An MRI scan of the brain showed no significant changes. The patient was diagnosed with ertapenem-induced neurotoxicity. We discontinued the antibiotic and switched to meropenem. Her neurological symptoms gradually improved and subsided within a week of stopping ertapenem. This case highlights the importance of clinical suspicion of ertapenem-induced neurotoxicity in elderly and frail patients with reduced renal function who present with unexplained neurological symptoms. Prompt recognition of the condition facilitates accurate diagnosis and management. Treatment is simple and involves discontinuing the offending drug, leading to favorable outcomes.

Indexed as

ertapenemertapenem-induced encephalopathygeriatric medicineneurotoxicityreduced renal function

Identifiers

PMID40462783
PMCPMC12132904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.